XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings per Share
9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Earnings per Share
(10) Earnings Per Share:
Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share reflect per share amounts that would have resulted if dilutive potential common stock had been converted to common stock in gain periods. The following reconciles amounts reported in the financial statements:
 
    
Nine Months Ended September 30,
 
    
2022
    
2021
 
    
Net Income
(In 000’s)
    
Weighted

Average

Number of

Shares

Outstanding
    
Per

Share

Amount
    
Net

Loss

(In 000’s)
   
Weighted

Average

Number of

Shares

Outstanding
    
Per

Share

Amount
 
Basic
   $ 35,279        1,965,334      $ 17.95      $ (5,021     1,994,177      $ (2.52
Effect of dilutive securities:
                                                    
Options (a)
     —          757,218        —                              
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
Diluted
   $ 35,279        2,722,522      $ 12.96      $ (5,021     1,994,177      $ (2.52
    
 
 
    
 
 
             
 
 
   
 
 
          
 
 
  
Three Months Ended September 30,
 
 
  
2022
 
  
2021
 
 
  
Net Income

(In 000’s)
 
  
Weighted

Average

Number of

Shares

Outstanding
 
  
Per

Share

Amount
 
  
Net

Loss

(In 000’s)
 
 
Weighted

Average

Number of

Shares

Outstanding
 
  
Per

Share

Amount
 
Basic
   $ 13,154        1,937,091      $ 6.79      $ (1,163     1,994,177      $ (0.58
Effect of dilutive securities:
                                                    
Options (a)
     —          757,815        —          —         —          —    
    
 
 
    
 
 
             
 
 
   
 
 
          
Diluted
   $ 13,154        2,694,906      $ 4.88      $ (1,163     1,994,177      $ (0.58
    
 
 
    
 
 
             
 
 
   
 
 
          
 
(a)
The effect of the 767,500 outstanding stock options is antidilutive for the nine and three months ended September 30, 2021 due to net loss for these periods.